This inventor holds 1 USPTO granted patent. Top assignee: Commonwealth Scientific and Industrial Research Organisation. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: John David Bentley: Innovator in Insulin Receptor Research
Introduction
John David Bentley is a notable inventor based in Macedon, Australia. He has made significant contributions to the field of biochemistry, particularly in the design of agonists and antagonists to the insulin-like growth factor (IGF) receptor. His work has implications for understanding insulin receptor binding and its related molecular structures.
Latest Patents
John David Bentley holds 1 patent for a method of designing agonists and antagonists to the IGF receptor. This patent discloses the identification of the human insulin receptor binding site sequence of certain spatial molecular structures conforming to such binding site. It also includes certain insulinomimetic sequences that encompass the binding site sequence.
Career Highlights
He is currently affiliated with the Commonwealth Scientific and Industrial Research Organisation, a leading research institution in Australia. His work at this organization has allowed him to explore innovative solutions in the field of insulin receptor research.
Collaborations
Throughout his career, John has collaborated with several professionals, including Paul Alexander Tulloch, who serves as a legal representative, and Leah Jane Cosgrove. These collaborations have enriched his research and contributed to the advancement of his projects.
Conclusion
John David Bentley's contributions to insulin receptor research highlight his innovative spirit and dedication to advancing scientific knowledge. His patent and collaborations reflect his commitment to improving our understanding of critical biological processes.